Evidence map›Paper›PMID 35306755›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice.

Jingwen Tian, Hyo Kyun Chung, Ji Sun Moon, Ha Thi Nga, Ho Yeop Lee, Jung Tae Kim, Joon Young Chang, Seul Gi Kang, Dongryeol Ryu, Xiangguo Che and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Bone-muscle interactions.Osteoporosis and sarcopenia · 2025
    Review
  6. Article
  7. Crosstalk between muscle and bone.Journal of bone and mineral metabolism · 2024
    Review
  8. Article
  9. Review
  10. Skeletal muscle proteome differs between youngFrontiers in aging neuroscience · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Sclerostin as a Putative Myokine in Sarcopenia.Endocrinology and metabolism (Seoul, Korea) · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Jingwen TianDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Hyo Kyun ChungResearch Center for Endocrine and Metabolic Diseases, Chungnam National University School of Medicine, Daejeon, Korea.
Ji Sun MoonLaboratory of Endocrinology and Immune System, Chungnam National University School of Medicine, Daejeon, Korea.
Ha Thi NgaDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Ho Yeop LeeDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Jung Tae KimDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Joon Young ChangDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Seul Gi KangDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Dongryeol RyuDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Korea.
Xiangguo CheDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University, Daegu, Korea.
Je-Yong ChoiDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, BK21 Plus KNU Biomedical Convergence Program, School of Medicine, Kyungpook National University, Daegu, Korea.
Masayuki TsukasakiDepartment of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Takayoshi SasakoDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Sang-Hee LeeBio-Electron Microscopy Research Center (104-Dong), Korea Basic Science Institute, Cheongju, Korea.
Minho ShongDepartment of Medical Science, Chungnam National University, Daejeon, Korea.
Hyon-Seung YiDepartment of Medical Science, Chungnam National University, Daejeon, Korea.ORCID 0000-0002-3767-1954
Chungnam National University · KRThe University of Tokyo · JPKorea Basic Science Institute · KRKyungpook National University · KRSamsung Medical Center · KRYanbian University · CN

Funding

Chungnam National University Hospital Research FundKorean Endocrine Society of Hyangseol Young Investigator AwardNational Research Foundation of Korea NRF-2017R1E1A1A01075126National Research Foundation of Korea NRF-2019M3E5D1A02068575National Research Foundation of Korea NRF-2021R1A5A8029876
6 · The paper itself

Abstract

backgroundMitochondrial oxidative phosphorylation (OxPhos) is a critical regulator of skeletal muscle mass and function. Although muscle atrophy due to mitochondrial dysfunction is closely associated with bone loss, the biological characteristics of the relationship between muscle and bone remain obscure. We showed that muscle atrophy caused by skeletal muscle-specific CR6-interacting factor 1 knockout (MKO) modulates the bone marrow (BM) inflammatory response, leading to low bone mass.

methodsMKO mice with lower muscle OxPhos were fed a normal chow or high-fat diet and then evaluated for muscle mass and function, and bone mineral density. Immunophenotyping of BM immune cells was also performed. BM transcriptomic analysis was used to identify key factors regulating bone mass in MKO mice. To determine the effects of BM-derived CXCL12 (C-X-C motif chemokine ligand 12) on regulation of bone homeostasis, a variety of BM niche-resident cells were treated with recombinant CXCL12. Vastus lateralis muscle and BM immune cell samples from 14 patients with hip fracture were investigated to examine the association between muscle function and BM inflammation.

resultsMKO mice exhibited significant reductions in both muscle mass and expression of OxPhos subunits but increased transcription of mitochondrial stress response-related genes in the extensor digitorum longus (P < 0.01). MKO mice showed a decline in grip strength and a higher drop rate in the wire hanging test (P < 0.01). Micro-computed tomography and von Kossa staining revealed that MKO mice developed a low mass phenotype in cortical and trabecular bone (P < 0.01). Transcriptomic analysis of the BM revealed that mitochondrial stress responses in skeletal muscles induce an inflammatory response and adipogenesis in the BM and that the CXCL12-CXCR4 (C-X-C chemokine receptor 4) axis is important for T-cell homing to the BM. Antagonism of CXCR4 attenuated BM inflammation and increased bone mass in MKO mice. In humans, patients with low body mass index (BMI = 17.2 ± 0.42 kg/m

conclusionsDefects in muscle mitochondrial OxPhos promote BM inflammation in mice, leading to decreased bone mass. Muscle mitochondrial dysfunction is linked to BM inflammatory cytokine secretion via the CXCL12-CXCR4 signalling axis, which is critical for inducing low bone mass.

Indexed as

Bone MarrowMuscle, SkeletalAnimalsHumansInflammationMaleMiceMuscular AtrophyX-Ray MicrotomographyBone lossBone marrowInflammationMitochondria

Identifiers

PMID35306755
PMCPMC9178379
OpenAlexW4220831349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.